| TTM
|
12/31/2025
|
12/31/2024
|
1/31/2023
|
1/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
|
-- | -- | -- | -0.28 | -14.81 |
|
Gross Profit
|
-- | -- | -- | -0.28 | -14.81 |
| Selling, General and Administrative Expenses
|
-7,535 | -7,535 | -4,326 | -1,974.01 | -1,623.13 |
|
Exploration Expenses
|
-17.42 | -- | -7.86 | -76.71 | -21.51 |
| Other Income/Expense, Operating
|
-3,898.32 | -867 | -717 | -102.94 | -75.26 |
|
Operating Income/Expenses
|
-7,299.33 | -8,402 | -5,043 | -2,153.67 | -1,719.90 |
|
Total Operating Profit/Loss
|
-7,299.33 | -8,402 | -5,043 | -2,153.94 | -1,734.70 |
| Total Net Finance Income/Expense
|
-1,613.06 | 919 | 38 | 260.57 | -10.77 |
| Net Investment Income
|
-1,826.17 | -1,294 | -224 | 943.62 | 57.23 |
| Irregular Income/Expenses
|
0 | 0 | 3,494 | 198.74 | -1.78 |
|
Other Income/Expense, Non-Operating
|
118.13 | 201 | 48 | -- | -- |
|
Non-Operating Income/Expenses, Total
|
-3,321.10 | -174 | 3,356 | 1,402.93 | 44.67 |
|
Pretax Income
|
-10,620.43 | -8,576 | -1,687 | -751.01 | -1,690.03 |
|
Provision for Income Tax
|
648 | 648 | 1,014 | -9.99 | 0 |
|
Net Income from Continuing Operations
|
-9,972.43 | -7,928 | -673 | -761.01 | -1,690.03 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-9,972.43 | -7,928 | -673 | -761.01 | -1,690.03 |
|
Net Income after Non-Controlling/Minority Interests
|
-9,972.43 | -7,928 | -673 | -761.01 | -1,690.03 |
|
Net Income Available to Common Stockholders
|
-9,972.43 | -7,928 | -673 | -761.01 | -1,690.03 |
|
Diluted Net Income Available to Common Stockholders
|
-9,972.43 | -7,928 | -673 | -761.01 | -1,690.03 |
| Basic EPS
|
-0.11 | -0.07 | -0.01 | -0.00 | -0.01 |
| Diluted EPS
|
-0.11 | -0.07 | -0.01 | -0.00 | -0.01 |
|
Basic Weighted Average Shares Outstanding
|
125,541.47 | 110,848.40 | 53,527.07 | 456,262.21 | 267,601.28 |
|
Diluted Weighted Average Shares Outstanding
|
125,541.47 | 110,848.40 | 53,527.07 | 456,262.21 | 267,601.28 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-9,007.37 | -9,495 | -1,725 | -1,011.59 | -1,679.26 |
|
EBITDA
|
-9,007.37 | -9,495 | -1,725 | -1,011.31 | -1,664.45 |
|
Normalized EBITDA
|
-6,912.37 | -7,963 | -5,626 | -2,153.67 | -1,673.13 |
|
Normalized Income
|
-7,877.43 | -6,511.76 | -3,598.75 | -1,686.32 | -1,698.71 |
|
Total Unusual Items
|
2,095 | 1,532 | -3,901 | -1,142.36 | -8.68 |
1/31/2022 - 2/16/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade